ARDX ARDELYX, INC.

NEUTRAL Impact: 3/10 Insider Cluster (4 insiders)
Horizon days Filed May 22, 2026 Processed 23d 13h ago
Insider cluster: 4 insiders, $0.1M total
Latest settled — T+5d
ARDX ▼ -8.32% at T+5d
NEUTRAL call ✗ call lost -8.32% · α vs SPY -9.40% · entry $6.25 → $5.73
Next anchor: T+20d in 8d
Last close $5.69 (close Jun 12) · -8.96% from $6.25 entry
Entry anchored
May 22, 03:59 PM ET
via Databento tick
T+1d
-1.44%
call -1.44% · α -1.39%
$6.16
settled 20d ago
T+5d
-8.32%
call -8.32% · α -9.40%
$5.73
settled 14d ago
T+20d
call — · α —
in 8d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Four C-suite insiders at Ardelyx sold $141K in open-market sales on the same day (May 21, 2026), including the CEO disposing of $94K worth. While the dollar amount is de minimis relative to the $1.6B market cap (~0.009%), the clustering of C-suite sales on a single date at identical price suggests coordination or a common 10b5-1 plan — not reactive selling to specific negative news. The historical calibration for ARDX shows neutral reports performed poorly on T+20 alpha, but the insider cluster data alone does not warrant a directional call given the trivial proportion of market cap.

Key Financial Metrics

Direction
selling
Total Value
$141.0K
Insiders
4

Actionable Insight

The size of insider sales is immaterial, even in a cluster of C-suite officers. Monitor upcoming earnings or pipeline disclosures for any fundamental change, but this cluster alone is not actionable. The identical execution price and date are more consistent with a coordinated 10b5-1 trading plan than with informed selling.

Key Facts

  • 4 corporate insiders (including CEO Michael Raab) sold shares on May 21, 2026
  • Total insider sales: ~$141K, or ~0.009% of $1.6B market cap
  • CEO Michael Raab's sale accounted for $93.6K (66% of total value)
  • All sales executed at the same price of $6.2675, suggesting a single trading plan window
  • Sales are open-market (code S) — not tax withholding or option exercises

Financial Impact

$141K total insider sales, representing 0.009% of market cap — trivial relative to company size

Risk Factors

  • Insiders could be diversifying ahead of a perceived risk — but dollar scale is too small to suggest this
  • Sequential 10b5-1 plans across officers may mask future larger sales

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (17 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ARDX-1779480758454
6 reports for ARDX
Performance horizon
Filters
Rows
Reports for ARDX — sortable, filterable
Type Now
May 22, 2026
23d ago
Insider Cluster
NEUTRAL ★ 2/10
$6.25 $5.52▼ −11.68%▼ −12.89%$5.69 (−8.96%)
May 22, 2026
23d ago
Insider Cluster
NEUTRAL ★ 3/10
$6.25 $5.73▼ −8.32%▼ −9.40%$5.69 (−8.96%)
May 19, 2026
26d ago
144
NEUTRAL ★ 2/10
$6.27 $6.25▼ −0.32%▼ −2.12%$5.69 (−9.25%)
Apr 27, 2026
6w ago
Press Release
NEUTRAL ★ 3/10
$5.99 $7.30▲ +21.87%▲ +21.47%$5.69 (−5.01%)
Apr 16, 2026
8w ago
Press Release
NEUTRAL ★ 3/10
$6.28 $5.96▼ −5.10%▼ −6.08%$5.69 (−9.39%)
Mar 9, 2026
13w ago
Press Release
NEUTRAL ★ 4/10
$6.12 $5.83▼ −4.74%▼ −3.83%$5.69 (−7.03%)
Showing 6 of 6

US Market Status

Market Closed — Opens in 3h 26m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access